Common Contracts
13 similar Underwriting Agreement contracts by Sundial Growers Inc., Byline Bancorp, Inc., Allegiance Bancshares, Inc., others
Mind Medicine (MindMed) Inc. 16,666,667 Common Shares (no par value per share) Underwriting AgreementUnderwriting Agreement • March 11th, 2024 • Mind Medicine (MindMed) Inc. • Medicinal chemicals & botanical products • New York
Mind Medicine (MindMed) Inc., a corporation incorporated under the laws of the Province of British Columbia (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, 16,666,667 common shares, having no par value per share (“Common Shares”) of the Company (said shares to be issued and sold by the Company being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the singular or plural as the context requires.
Customers Bancorp, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • August 6th, 2021 • Customers Bancorp, Inc. • State commercial banks • New York
SUNDIAL GROWERS INC. 60,500,000 SERIES A UNITS CONSISTING OF 60,500,000 COMMON SHARES AND WARRANTS TO PURCHASE 30,250,000 COMMON SHARES 14,000,000 SERIES B UNITS CONSISTING OF 14,000,000 PRE-FUNDED WARRANTS TO PURCHASE 14,000,000COMMON SHARES AND...Underwriting Agreement • February 3rd, 2021 • Sundial Growers Inc. • Medicinal chemicals & botanical products • New York
SUNDIAL GROWERS INC. 100,000,000 SERIES A UNITS CONSISTING OF 100,000,000 COMMON SHARES AND WARRANTS TO PURCHASE 50,000,000 COMMON SHARES 33,333,334 SERIES B UNITS CONSISTING OF 33,333,334 PRE-FUNDED WARRANTS TO PURCHASE 33,333,334 COMMON SHARES AND...Underwriting Agreement • February 1st, 2021 • Sundial Growers Inc. • Medicinal chemicals & botanical products • New York
VERITEX HOLDINGS, INC.Underwriting Agreement • October 5th, 2020 • Veritex Holdings, Inc. • State commercial banks • New York
Veritex Holdings, Inc., a Texas corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A hereto (the “Underwriters”) pursuant to the terms set forth herein (this “Agreement”) $125,000,000 aggregate principal amount of the Company’s 4.125% Fixed-to-Floating Rate Subordinated Notes due 2030 (the “Securities”). The Securities will be issued pursuant to an indenture (the “Base Indenture”), to be dated as of the Closing Time (as defined below), between the Company and UMB Bank, N.A., as trustee (the “Trustee”), as supplemented by a supplemental indenture thereto relating to the Securities, to be dated as of the Closing Time, between the Company and the Trustee (the “Supplemental Indenture” and, together with the Base Indenture, the “Indenture”). Keefe, Bruyette & Woods, Inc. (“KBW”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Securities.
SUNDIAL GROWERS INC. 25,820,000 SERIES A UNITS CONSISTING OF 25,820,000 COMMON SHARES AND WARRANTS TO PURCHASE 25,820,000 COMMON SHARES 14,280,000 SERIES B UNITS CONSISTING OF 14,280,000 PRE-FUNDED WARRANTS TO PURCHASE 14,280,000 COMMON SHARES AND...Underwriting Agreement • August 14th, 2020 • Sundial Growers Inc. • Medicinal chemicals & botanical products • New York
Byline Bancorp, Inc.Underwriting Agreement • August 3rd, 2020 • Byline Bancorp, Inc. • State commercial banks • New York
Byline Bancorp, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A hereto (the “Underwriters”) pursuant to the terms set forth herein (this “Agreement”) $25,000,000 aggregate principal amount of the Company’s 6.000% Fixed-to-Floating Rate Subordinated Notes due July 1, 2030 (the “Securities”). The Securities will form a part of the same series as, and for U.S. federal income tax purposes are intended to be issued in a “qualified reopening” of, the Company’s outstanding 6.000% Fixed-to-Floating Rate Subordinated Notes, issued June 26, 2020 (the “Original Securities”). The Securities will have the same terms as the Original Securities in all respects, other than with respect to the offering price, the issue date or the payment of interest accruing prior to the issue date. The Securities will be issued with no more than a de minimis amount of original issue discount (determined in accordance with applicable U.S. federal
Byline Bancorp, Inc.Underwriting Agreement • June 26th, 2020 • Byline Bancorp, Inc. • State commercial banks • New York
Byline Bancorp, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A hereto (the “Underwriters”) pursuant to the terms set forth herein (this “Agreement”) $50,000,000 aggregate principal amount of the Company’s 6.000% Fixed-to-Floating Rate Subordinated Notes due July 1, 2030 (the “Securities”). The Securities will be issued pursuant to an indenture, to be dated as of the Closing Time (as defined below) (the “Base Indenture”), between the Company and U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by a supplemental indenture thereto relating to the Securities, to be dated as of the Closing Time, between the Company and the Trustee (the “Supplemental Indenture” and, together with the Base Indenture, the “Indenture”). Keefe, Bruyette & Woods, Inc. (“KBW”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and
ConnectOne Bancorp, Inc.Underwriting Agreement • June 15th, 2020 • ConnectOne Bancorp, Inc. • State commercial banks • New York
ConnectOne Bancorp, Inc., a New Jersey corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A hereto (the “Underwriters”) pursuant to the terms set forth herein (this “Agreement”) $75,000,000 aggregate principal amount of the Company’s 5.750% Fixed-to-Floating Rate Subordinated Notes due June 15, 2030 (the “Securities”). The Securities will be issued pursuant to an indenture, dated as of January 17, 2018 (the “Base Indenture”), between the Company and U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by a second supplemental indenture thereto relating to the Securities, to be dated as of the Closing Time, between the Company and the Trustee (the “Supplemental Indenture” and, together with the Base Indenture, the “Indenture”). Keefe, Bruyette & Woods, Inc. (“KBW”) and Goldman Sachs & Co. LLC (“Goldman Sachs”) have agreed to act as Representatives of the several Underwriters (in such capacity, the “Representatives
First Financial Bancorp.Underwriting Agreement • April 30th, 2020 • First Financial Bancorp /Oh/ • National commercial banks • New York
First Financial Bancorp., an Ohio corporation (the "Company"), proposes to issue and sell to the underwriters named in Schedule A hereto (the "Underwriters") pursuant to the terms set forth herein (this "Agreement") $150,000,000 aggregate principal amount of the Company's 5.25% Fixed-to-Floating Rate Subordinated Notes due May 15, 2030 (the "Securities"). The Securities will be issued pursuant to an indenture, dated as of August 25, 2015 (the "Base Indenture"), between the Company and Wells Fargo Bank, National Association, as trustee (the "Trustee"), as supplemented by a second supplemental indenture thereto relating to the Securities, to be dated as of the Closing Time, between the Company and the Trustee (the "Supplemental Indenture" and, together with the Base Indenture, the "Indenture"). Keefe, Bruyette & Woods, Inc. ("KBW") has agreed to act as representative of the several Underwriters (in such capacity, the "Representative") in connection with the offering and sale of the Secur
Allegiance Bancshares, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • September 24th, 2019 • Allegiance Bancshares, Inc. • State commercial banks • New York
Allegiance Bancshares, Inc., a Texas corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A hereto (the “Underwriters”) pursuant to the terms set forth herein (this “Agreement”) $60,000,000 aggregate principal amount of the Company’s 4.70% Fixed-to-Floating Rate Subordinated Notes due October 1, 2029 (the “Securities”). The Securities will be issued pursuant to an indenture, dated September 20, 2019 (the “Base Indenture”), between the Company and U.S. Bank, National Association, as trustee (the “Trustee”), as supplemented by a supplemental indenture thereto relating to the Securities, to be dated as of the Closing Time, between the Company and the Trustee (the “Supplemental Indenture” and, together with the Base Indenture, the “Indenture”). Keefe, Bruyette & Woods, Inc. (“KBW”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Securitie
QCR HOLDINGS, INC.Underwriting Agreement • February 12th, 2019 • QCR Holdings Inc • State commercial banks • New York
QCR Holdings, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A hereto (the “Underwriters”) pursuant to the terms set forth herein (this “Agreement”) $65,000,000 aggregate principal amount of the Company’s 5.375% Fixed-to-Floating Rate Subordinated Notes due February 15, 2029 (the “Securities”). The Securities will be issued pursuant to an indenture (the “Base Indenture”), to be dated as of the Closing Date (as defined below), between the Company and Wilmington Trust National Association, as trustee (the “Trustee”), as supplemented by a supplemental indenture (the “Supplemental Indenture” and, together with the Base Indenture, the “Indenture”). Keefe, Bruyette & Woods, Inc. (“KBW”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Securities.
REDHILL BIOPHARMA LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • August 13th, 2018 • RedHill Biopharma Ltd. • Pharmaceutical preparations • New York
